Trial Profile
Safety and efficacy of Pirfenidone in subjects with idiopathic pulmonary fibrosis (IPF) in a real life setting.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2016
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 14 Jan 2016 New trial record